ARCHIVES

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

Trials Approved by NCI CTEP For The Month of February

February 24, 2012

Learning From Europeans, U.S. Oncologists Consider Role For Oxaliplatin, 5-FU Infusion

May 31, 2002

House Bill Seeks Coverage for Care Planning, Reviving Proposal Once Maligned By The Right

September 6, 2013

More Radiation Increases Prostate Cancer Response

August 30, 2002

NIDDK Funds Trial On treatment Of Chronic Hepatitis C

August 13, 1999

IARC Finds Limited Evidence That Residential Magnetic Fields Raise Leukemia Risk.

June 29, 2001